Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-025009
Filing Date
2019-07-16
Accepted
2019-07-16 07:15:24
Documents
82
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 FY19 10-K kalv-10k_20190430.htm 10-K 2866521
2 EX-10.5 kalv-ex105_459.htm EX-10.5 121769
3 EX-10.6 kalv-ex106_460.htm EX-10.6 122572
4 EX-10.13 kalv-ex1013_461.htm EX-10.13 123854
5 EX-10.21 kalv-ex1021_462.htm EX-10.21 122525
6 EX-10.22 kalv-ex1022_463.htm EX-10.22 122339
7 EX-10.23 kalv-ex1023_554.htm EX-10.23 42415
8 EX-10.24 kalv-ex1024_464.htm EX-10.24 23597
9 EX-23.1 kalv-ex231_7.htm EX-23.1 2485
10 EX-31.1 kalv-ex311_10.htm EX-31.1 19749
11 EX-31.2 kalv-ex312_8.htm EX-31.2 19861
12 EX-32.1 kalv-ex321_9.htm EX-32.1 6583
13 EX-32.2 kalv-ex322_12.htm EX-32.2 6842
14 GRAPHIC gyiy2hrkjmit000002.jpg GRAPHIC 9125
15 GRAPHIC gyiy2hrkjmit000004.jpg GRAPHIC 29975
16 GRAPHIC gyiy2hrkjmit000001.jpg GRAPHIC 9890
17 GRAPHIC gyiy2hrkjmit000003.jpg GRAPHIC 12158
  Complete submission text file 0001564590-19-025009.txt   8578838

Data Files

Seq Description Document Type Size
18 XBRL INSTANCE DOCUMENT kalv-20190430.xml EX-101.INS 1448253
19 XBRL TAXONOMY EXTENSION SCHEMA kalv-20190430.xsd EX-101.SCH 51939
20 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalv-20190430_cal.xml EX-101.CAL 59247
21 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalv-20190430_def.xml EX-101.DEF 150401
22 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20190430_lab.xml EX-101.LAB 418812
23 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20190430_pre.xml EX-101.PRE 315037
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-36830 | Film No.: 19956200
SIC: 2834 Pharmaceutical Preparations